Cargando…

Characterization of TET and IDH gene expression in chronic lymphocytic leukemia: comparison with normal B cells and prognostic significance

BACKGROUND: Chronic lymphocytic leukemia (CLL) is the most common hematological malignancy in western countries, characterized by a heterogeneous clinical course. Although genetic studies have identified chromosomal aberrations or specific mutations, epigenetic changes have been poorly characterized...

Descripción completa

Detalles Bibliográficos
Autores principales:	Van Damme, Michaël, Crompot, Emerence, Meuleman, Nathalie, Maerevoet, Marie, Mineur, Philippe, Bron, Dominique, Lagneaux, Laurence, Stamatopoulos, Basile
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5141649/ https://www.ncbi.nlm.nih.gov/pubmed/27980696 http://dx.doi.org/10.1186/s13148-016-0298-y

Ejemplares similares

Extracellular vesicles of bone marrow stromal cells rescue chronic lymphocytic leukemia B cells from apoptosis, enhance their migration and induce gene expression modifications
por: Crompot, Emerence, et al.
Publicado: (2017)

Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles
por: Dubois, Nathan, et al.
Publicado: (2020)

Avoiding False Positive Antigen Detection by Flow Cytometry on Blood Cell Derived Microparticles: The Importance of an Appropriate Negative Control
por: Crompot, Emerence, et al.
Publicado: (2015)

A Molecular Score by Quantitative PCR as a New Prognostic Tool at Diagnosis for Chronic Lymphocytic Leukemia Patients
por: Stamatopoulos, Basile, et al.
Publicado: (2010)

P610: EXTRACELLULAR VESICLES FROM CHRONIC LYMPHOCYTIC LEUKEMIA CELLS INDUCE THE DIFFERENTIATION OF MONOCYTES INTO NURSE-LIKE CELLS
por: Dubois, Nathan, et al.
Publicado: (2023)

Comparison and immunobiological characterization of retinoic acid inducible gene-I-like receptor expression in mesenchymal stromal cells
por: Raicevic, Gordana, et al.
Publicado: (2017)

Aging of Bone Marrow Mesenchymal Stromal Cells: Hematopoiesis Disturbances and Potential Role in the Development of Hematologic Cancers
por: Massaro, Fulvio, et al.
Publicado: (2020)

Extracellular vesicles in hematological malignancies: EV-dence for reshaping the tumoral microenvironment
por: Van Morckhoven, David, et al.
Publicado: (2023)

Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Natural Nanocarriers: Concise Review
por: Draguet, Florian, et al.
Publicado: (2023)

Evidences of Early Senescence in Multiple Myeloma Bone Marrow Mesenchymal Stromal Cells
por: André, Thibaud, et al.
Publicado: (2013)

Gene expression pattern of functional neuronal cells derived from human bone marrow mesenchymal stromal cells
por: Tondreau, Tatiana, et al.
Publicado: (2008)

Extracellular Vesicles Derived from Human Umbilical Cord Mesenchymal Stromal Cells as an Efficient Nanocarrier to Deliver siRNA or Drug to Pancreatic Cancer Cells
por: Draguet, Florian, et al.
Publicado: (2023)

Foreskin-derived mesenchymal stromal cells with aldehyde dehydrogenase activity: isolation and gene profiling
por: Najar, Mehdi, et al.
Publicado: (2018)

Impact of Bone Marrow miR-21 Expression on Acute Myeloid Leukemia T Lymphocyte Fragility and Dysfunction
por: Moussa Agha, Douâa, et al.
Publicado: (2020)

Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective Analysis
por: Massaro, Fulvio, et al.
Publicado: (2022)

Mesenchymal Stromal Cells and Toll-Like Receptor Priming: A Critical Review
por: Najar, Mehdi, et al.
Publicado: (2017)

Data on nitric oxide production by human bone marrow-derived mesenchymal stromal cells
por: Najar, Mehdi, et al.
Publicado: (2016)

Lipoprotein Lipase SNPs rs13702 and rs301 Correlate with Clinical Outcome in Chronic Lymphocytic Leukemia Patients
por: Rombout, Ans, et al.
Publicado: (2015)

Advanced Glycation End-Products-, C-Type Lectin- and Cysteinyl/ Leukotriene-Receptors in Distinct Mesenchymal Stromal Cell Populations: Differential Transcriptional Profiles in Response to Inflammation
por: Najar, Mehdi, et al.
Publicado: (2018)

Data on HO-1 and CD200 protein secretion during T-cells and mesenchymal stromal cells co-cultures
por: Fayyad-Kazan, Mohammad, et al.
Publicado: (2017)

Cross-Talk Between Mesenchymal Stromal Cells (MSCs) and Endothelial Progenitor Cells (EPCs) in Bone Regeneration
por: Bouland, Cyril, et al.
Publicado: (2021)

TET2 Overexpression in Chronic Lymphocytic Leukemia Is Unrelated to the Presence of TET2 Variations
por: Hernández-Sánchez, María, et al.
Publicado: (2014)

Age-related changes in the BACH2 and PRDM1 genes in lymphocytes from healthy donors and chronic lymphocytic leukemia patients
por: Chi, Vu Luan Dang, et al.
Publicado: (2019)

New Anti-Leukemic Effect of Carvacrol and Thymol Combination through Synergistic Induction of Different Cell Death Pathways
por: Bouhtit, Fatima, et al.
Publicado: (2021)

TET2, ASXL1, IDH1, and IDH2 Single Nucleotide Polymorphisms in Turkish Patients with Chronic Myeloproliferative Neoplasms
por: Soyer, Nur, et al.
Publicado: (2017)

mIDH-associated DNA hypermethylation in acute myeloid leukemia reflects differentiation blockage rather than inhibition of TET-mediated demethylation
por: Wiehle, Laura, et al.
Publicado: (2017)

IDH1/IDH2 Inhibition in Acute Myeloid Leukemia
por: Cerchione, Claudio, et al.
Publicado: (2021)

TET2/IDH1/2/WT1 and NPM1 Mutations Influence the RUNX1 Expression Correlations in Acute Myeloid Leukemia
por: Pasca, Sergiu, et al.
Publicado: (2020)

T cells in chronic lymphocytic leukemia: can they fight?
por: Vardi, Anna, et al.
Publicado: (2017)

T Cell Defects and Immunotherapy in Chronic Lymphocytic Leukemia
por: Vlachonikola, Elisavet, et al.
Publicado: (2021)

The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal Cells
por: Buyl, Karolien, et al.
Publicado: (2020)

Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2
por: Guilhamon, Paul, et al.
Publicado: (2013)

Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma()()
por: Stasik, Sebastian, et al.
Publicado: (2020)

Distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells
por: Fortin, Jerome, et al.
Publicado: (2023)

Identification of Acute Myeloid Leukemia Bone Marrow Circulating MicroRNAs
por: Moussa Agha, Douâa, et al.
Publicado: (2020)

The Prognostic Significance of TET2 Single Nucleotide Polymorphism in Egyptian Chronic Myeloid Leukemia
por: Hamed, Nahla A., et al.
Publicado: (2020)

The Frequency and Clinical Significance of IDH1 Mutations in Chinese Acute Myeloid Leukemia Patients
por: Guan, Lixun, et al.
Publicado: (2013)

Study of the microRNA expression profile of foreskin derived mesenchymal stromal cells following inflammation priming
por: Fayyad-Kazan, Hussein, et al.
Publicado: (2017)

Changes in IDH2, TET2 and KDM2B Gene Expression After Treatment With Classic Chemotherapeutic Agents and Decitabine in Myelogenous Leukemia Cell Lines
por: Alves, Jayse, et al.
Publicado: (2019)

T Cells in Chronic Lymphocytic Leukemia: A Two-Edged Sword
por: Vlachonikola, Elisavet, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tes9djt8dovsgbd7jlref3t7g9